Sujets

Sur cette page, les lecteurs peuvent obtenir une liste de documents classifiés par thèmes. Cliquez sur le nom du thème pour voir affichées les sous-thèmes ou pour revenir aux thèmes principaux. Cliquez sur l'icône d'un sous-thème pour obtenir la liste des documents qui s'y rapportent. Les publications sont disponibles en HTML, PDF , DOC ou XLS format. Veuillez cliquer sur l'icône correspondante pour accéder à la publication. La publication est disponible uniquement en format PDF lorsque l'icône PDF est située sur la page de couverture de la publication. Si l'icône PDF est située près du titre de la publication, les formats HTML et PDF sont disponibles.
Étendre le menu Sous-collections.
502 documents en 1 page
 
 
 
 
Ouvrir ce document et afficher son contenu

2015 Global Survey on Health Technology Assessment by National Authorities. Main Findings

An:

2015;

Pages:

40;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Abstract Poster Book

An:

2015;

Pages:

32;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Country Poster Book

An:

2015;

Pages:

44;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Abstracts from the 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015

An:

2015;

Pages:

30;

Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Accelerating access to essential medicines in the WHO South-East Asia Region: opportunities for greater engagement and better evidence. (WHO South-East Asia Journal of Public Health | September 2018)

An:

2018;

Pages:

76;


 
Ouvrir ce document et afficher son contenu

Access to Antiretroviral Drugs in Low- and Middle-income Countries: Technical Report, July 2014

An:

2014;

Pages:

44;


Régions:

 
Ouvrir ce document et afficher son contenu

Access to Cancer Treatment: A Study of Medicine Pricing Issues with Recommendations for Improving Access to Cancer Medication

An:

2015;

Pages:

54;

Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Access to Insulin: Applying the Concept of Security of Supply To Medicines. (Bull World Health Organ 2019; 97:358–364)

An:

2019;

Pages:

7;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Access to Insulin: Current Challenges and Constraints. October 2015

An:

2015;

Pages:

30;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Access to New Medicines in Europe: Technical Review of Policy Initiatives and Opportunities for Collaboration and Research [Russian]

An:

2015;

Pages:

184;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries

An:

2015;

Pages:

24;

Régions:

 
Ouvrir ce document et afficher son contenu

Advance Price or Purchase Commitments to Create Markets for Treatments for Diseases of Poverty: Lessons from Three Policies

An:

2005;

Pages:

7;


Régions:

 
Ouvrir ce document et afficher son contenu

An Antibiotic’s Journey from Marketing Authorization to Use, Norway (Bull World Health Organ 2017;95:220–226)

An:

2017;

Pages:

7;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Approaches to improving access to essential cancer medicines in the WHO South-East Asia Region. (WHO South-East Asia Journal of Public Health | September 2018)

An:

2018;

Pages:

5;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Availability of Medicines in Public Sector Health Facilities of Two North Indian States

An:

2015;

Pages:

11;

Documents similaires:

Pays:

 
Ouvrir ce document et afficher son contenu

Better Life Through Medicine—let’s Leave No One Behind. (Essential Medicines for Universal Health Coverage - Comment. The Lancet Commission on Essential Medicines Policies)

An:

2016;

Pages:

2;

Régions:

 
Ouvrir ce document et afficher son contenu

Can People Afford to Pay for Health Care? New Evidence on Financial Protection in Europe. Copenhagen: WHO Regional Office for Europe; 2019

An:

2019;

Pages:

144;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Challenges and Opportunities in Improving Access to Medicines Through Efficient Public Procurement In WHO European Region

An:

2016;

Pages:

106;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Challenges Constraining Access to Insulin in the Private-sector Market Of Delhi, India. (With online supplementary appendix)

An:

2016;

Pages:

24;

Documents similaires:

Pays:

 
Ouvrir ce document et afficher son contenu

Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies

An:

2019;

Pages:

11;

Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Consultation on Financing of Essential Medicines. Manila, Philippines, 4-6 October 2006

An:

2007;

Pages:

58;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Cost Savings of Switching Private Sector Consumption from Originator Brand Medicines to Generic Equivalents. World Health Report (2010) - Background Paper, 35

An:

2010;

Pages:

11;


Régions:

 
Ouvrir ce document et afficher son contenu

Cross-Sectional Pilot Study to Monitor the Availability, Dispensed Prices, and Affordability of Opioids Around the Globe

An:

2014;

Pages:

12;

Régions:

 
Ouvrir ce document et afficher son contenu

Developing an Approach for Using Health Technology Assessments in Reimbursement Systems for Medical Products. Geneva, Switzerland, July 20-21, 2015

An:

2015;

Pages:

31;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Effect of Novartis Access on Availability and Price of Non-Communicable Disease Medicines in Kenya: A Cluster-Randomised Controlled Trial

An:

2019;

Pages:

11;

Documents similaires:

Pays:

 
Ouvrir ce document et afficher son contenu

Ensuring that Essential Medicines are also Affordable Medicines: Challenges and Options. Discussion Paper UNITAID

An:

2016;

Pages:

52;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment. (WHO South-East Asia Journal of Public Health | September 2018)

An:

2018;

Pages:

9;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Essential Medicines for Universal Health Coverage. (Essential Medicines for Universal Health Coverage - Comment. The Lancet Commission on Essential Medicines Policies)

An:

2016;

Pages:

2;

Régions:

 
Ouvrir ce document et afficher son contenu

Essential Medicines for Universal Health Coverage. (The Lancet Commission on Essential Medicines Policies)

An:

2016;

Pages:

74;


Régions:

 
Ouvrir ce document et afficher son contenu

Estimated Costs of Production and Potential Prices for the WHO Essential Medicines List

An:

2018;

Pages:

8;

Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis

An:

2017;

Pages:

11;

Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Ethiopia National Health Insurance Scale-Up Assessment on Medicines Financing, Use, and Benefit Management: Findings, Implications, and Recommendations. August 2016

An:

2016;

Pages:

78;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Evaluating Access to Essential Medicines for Treating Childhood Cancers: A Medicines Availability, Price and Affordability Study in New Delhi, India

An:

2019;

Pages:

11;

Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Evaluating Availability and Price of Essential Medicines in Boston Area (Massachusetts, USA) Using WHO/HAI Methodology. (With Additional File 1: Supplementary Details on Survey Methods, Data and Statistical Analyses)

An:

2016;

Pages:

47;

Régions:

 
Ouvrir ce document et afficher son contenu

Fair Insurance Guide. Taming Big Pharma: Assessing How Insurers Push Pharmaceutical Companies to Improve Access to Medicine and Pay Fair Taxes. 25 April 2019

An:

2019;

Pages:

95;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Fair Pricing Forum 2019 Meeting Report: Johannesburg, South Africa, 11–13 April 2019. World Health Organization

An:

2019;

Pages:

23;


Régions:

 
Ouvrir ce document et afficher son contenu

Fair Pricing Forum. Informal Advisory Group Meeting, WHO Headquarters, Geneva, 22 - 24 November 2016

An:

2017;

Pages:

24;


Régions:

 
Ouvrir ce document et afficher son contenu

Fatima Suleman: Making Medicines More Widely Available. (Bull World Health Organ 2017;95:800–801)

An:

2017;

Pages:

2;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

The Fifth Meeting on Access to Medicines Under Universal Health Coverage in the Asia Pacific Region. Strategies for Better Access – What Works? Summary Report. 19–20 Sep 2018, New Delhi, India Copy About Title Case

An:

2018;

Pages:

4;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

First Meeting on Access to Medicines under Universal Health Coverage in the Asia Pacific Region. 18–19 September 2014, Seoul, Republic of Korea

An:

2014;

Pages:

126;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Fourth Meeting on Access to Medicines Under Universal Health Coverage in the Asia Pacific Region. 26–27 September 2017, Seoul, Republic of Korea

An:

2017;

Pages:

90;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

Global Access to Hepatitis Drugs and Diagnostics Consultation with Pharmaceutical and Diagnostics Companies. 16 June 2014, Geneva, Switzerland

An:

2014;

Pages:

24;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

The Global Drug Facility as an intervention in the market for tuberculosis drugs (Bull World Health Organ 2015;93:237–248A)

An:

2015;

Pages:

13;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Global Report on Access to Hepatitis C Treatment. Focus on Overcoming Barriers. October 2016

An:

2016;

Pages:

68;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Global Report on Diabetes

An:

2016;

Pages:

88;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals

An:

2015;

Pages:

216;


Régions:

 
Ouvrir ce document et afficher son contenu

Health Technology Assessment and Health Policy-making in Europe. Current Status, Challenges and Potential. Observatory Studies Series No 14

An:

2008;

Pages:

197;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

High Cost of Medicines in Ukraine: Factors and Price Components. February 2015

An:

2015;

Pages:

36;


Pays:

 
Ouvrir ce document et afficher son contenu

Improved Effectiveness of Generic Medicine Markets in Hungary. Analysis and Recommendations

An:

2015;

Pages:

98;


Documents similaires:

Pays:

 
Ouvrir ce document et afficher son contenu

Informal Advisory Group on the Availability and Affordability of Cancer Medicines, Report of the meeting 4 – 6 April 2018. Geneva, Switzerland World Health Organization; 2018

An:

2018;

Pages:

13;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Informal Consultation on Access to Hepatitis Medicines in Upper-Middle-and High Income Countries. 21–22 August 2017, Manila, Philippines

An:

2017;

Pages:

23;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Innovative payment models for high-cost innovative medicines. Report of the Expert Panel on effective ways of investing in Health (EXPH)

An:

2018;

Pages:

81;


Documents similaires:

 
Ouvrir ce document et afficher son contenu

International Price Comparison of Pharmaceuticals 2016. A Volume Based Analysis of Swedish Pharmaceutical Prices Relative to 19 Other European Countries.

An:

2017;

Pages:

85;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?

An:

2016;

Pages:

13;

Régions:

 
Ouvrir ce document et afficher son contenu

Making Medicines in Africa The Political Economy of Industrializing for Local Health (International Political Economy Series)

An:

2015;

Pages:

358;

Documents similaires:

 
Ouvrir ce document et afficher son contenu

MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)

An:

2012;

Pages:

1088;


Documents similaires:

Régions:

 
Ouvrir ce document et afficher son contenu

Medicine Price Components in Uganda, October 2015

An:

2015;

Pages:

24;


Pays:

 
Ouvrir ce document et afficher son contenu

Medicines Reimbursement Policies in Europe (2018)

An:

2018;

Pages:

200;


Documents similaires:

Régions: